CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 11,024	$ 14,546
Marketable debt securities	1,946	1,285
Receivables	9,017	8,501
Inventories	2,137	2,074
Other current assets	5,037	3,786
Total current assets	29,161	30,192
Property, plant and equipment	5,795	5,886
Goodwill	20,529	20,547
Other intangible assets	48,065	53,243
Deferred income taxes	650	1,161
Marketable debt securities	143	433
Other non-current assets	6,454	7,019
Total Assets	110,797	118,481
Current Liabilities:
Short-term debt obligations	2,655	2,340
Accounts payable	3,609	2,713
Other current liabilities	12,727	14,027
Total Current Liabilities	18,991	19,080
Deferred income taxes	4,931	5,407
Long-term debt	42,503	48,336
Other non-current liabilities	7,498	7,776
Total Liabilities	73,923	80,599
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock	0	0
Common stock	292	292
Capital in excess of par value of stock	44,064	44,325
Accumulated other comprehensive loss	(1,518)	(1,839)
Retained earnings	22,168	21,281
Less cost of treasury stock	(28,198)	(26,237)
Total Bristol-Myers Squibb Company Shareholders' Equity	36,808	37,822
Noncontrolling Interest	66	60
Total Equity	36,874	37,882
Total Liabilities and Equity	$ 110,797	$ 118,481